PRX5 identified as key regulator in colorectal cancer stem cell formation
The study highlights PRX5's role in sustaining colorectal cancer stem cell identity and tumorigenicity.
Asset / Drug
Drug and asset intelligence for PRX5 with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.